Vote Scores
Filings read through

Vertex Pharmaceuticals Incorporated: how funds voted at the meeting of 13 May 2026

Meeting
Season
year to 30 June 2026
Filers reporting
1,509
Ballot items
6

1,509 filers on Form N-PX reported votes at the Vertex Pharmaceuticals Incorporated meeting of 13 May 2026. The records fall into 6 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    10 nominees. 93.9% of the reported votes are for. 99 filers withheld from or voted against at least one nominee.

    11,737 vote records from 400 filers. 5 of the 399 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 54 fund families
    • For 54
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    2,570 vote records from 1,494 filers. 98 of the 1,452 filers that marked the item voted against management. 42 filers gave no management mark.

    • Positions of 55 fund families
    • For 54
    • Against 1
    • Against management 1
  3. Item 3: Audit-related items (auditor ratification)

    1,139 vote records from 399 filers. 6 of the 398 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 54 fund families
    • For 54
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    1,189 vote records from 407 filers. 14 of the 404 filers that marked the item voted against management. 3 filers gave no management mark.

    • Positions of 54 fund families
    • For 52
    • Against 2
    • Against management 2
  5. Item 5: Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written...

    1,089 vote records from 382 filers. 200 of the 382 filers that marked the item voted against management.

    • Positions of 54 fund families
    • For 27
    • Against 27
    • Against management 27
  6. Item 6: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    22 vote records from 13 filers. 7 of the 11 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 2 fund families
    • Against 1
    • Split or no vote 1
    • Against management 1

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Vertex Pharmaceuticals Incorporated, meeting of 13 May 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor5. Proposal
AllianceBernsteinForForFor, against management
AllspringForForAgainst
American CenturyForForAgainst
BairdForNo reportNo report
BlackRock and iSharesForForAgainst
BNY MellonForForFor, against management
Brighthouse FundsForForAgainst
Capital Group and American FundsForForFor, against management
Charles SchwabForForAgainst
Columbia ThreadneedleForForFor, against management
DimensionalForForAgainst
DWSAgainst, against managementForFor, against management
EquitableForForFor, against management
Federated HermesForForAgainst
FidelityForForAgainst
First TrustForForFor, against management
Franklin TempletonForForFor, against management
Global XForForFor, against management
Goldman SachsForForAgainst
Guggenheim and RydexForForFor, against management
Harbor FundsForForAgainst
Hartford FundsForForFor, against management
InvescoForForFor, against management
J.P. MorganForForAgainst
Jackson National fundsForForFor, against management
Janus HendersonForForAgainst
John Hancock and ManulifeForForFor, against management
Lincoln FinancialForForFor, against management
Lord AbbettForForAgainst
Macquarie and Delaware FundsForForFor, against management
MassMutualForForAgainst
MFSForForFor, against management
Morgan Stanley, Eaton Vance and CalvertForForFor, against management
NationwideForForAgainst
Natixis and Loomis SaylesForForAgainst
Neuberger BermanForForAgainst
Northern Trust and FlexSharesForForAgainst
Nuveen and TIAAForForAgainst
Pacific Life fundsForForAgainst
PGIM and PrudentialForForAgainst
PIMCOForForFor, against management
PrincipalForForAgainst
ProShares and ProFundsForForFor, against management
Russell InvestmentsForForFor, against management
SEIForForFor, against management
State Street and SPDRForForAgainst
T. Rowe PriceForForAgainst
ThriventForForAgainst
TransamericaForForFor, against management
VanEckForForFor, against management
VanguardForForAgainst
Victory CapitalForForFor, against management
VirtusForForFor, against management
VoyaForForAgainst
WisdomTreeForForFor, against management

Questions

How many filers reported votes at the Vertex Pharmaceuticals Incorporated meeting?
1,509 Form N-PX filers reported votes at the meeting of 13 May 2026. On say-on-pay, 98 of 1,452 filers that marked the item voted against management (6.7%). The filings show one separate proposal from security holders.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Vertex Pharmaceuticals Incorporated reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Vertex Pharmaceuticals Incorporated with a meeting date within three days of 13 May 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .